Biofilm formation avoids complement immunity and phagocytosis of Streptococcus pneumoniae

Infection and Immunity

Volumn 81, Issue 7, 2013, Pages 2606-2615

  Domenech, Mirian ^a,b   Ramos Sevillano, Elisa ^a,b   García, Ernesto ^a,b   Moscoso, Miriam ^a,b   Yuste, Jose ^b,c  

^a CENTRO DE INVESTIGACIONES BIOLÓGICAS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3B; COMPLEMENT FACTOR H;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; BIOFILM; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; MICROBIAL COMMUNITY; MOLECULAR RECOGNITION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADULT; BACTERIAL PROTEINS; BIOFILMS; COMPLEMENT C3B; COMPLEMENT C4B-BINDING PROTEIN; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT PATHWAY, CLASSICAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MALE; MICROSCOPY, CONFOCAL; NEUTROPHILS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 84879456358     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00491-13     Document Type: Article

References (47)

1. Wardlaw T, Salama P, Johansson EW, Mason E. 2006. Pneumonia: the leading killer of children. Lancet 368:1048-1050.
2. Hall-Stoodley L, Hu FZ, Gieseke A, Nistico L, Nguyen D, Hayes J, Forbes M, Greenberg DP, Dice B, Burrows A, Wackym PA, Stoodley P, Post JC, Ehrlich GD, Kerschner JE. 2006. Direct detection of bacterial biofilms on the middle-ear mucosa of children with chronic otitis media. JAMA 296:202-211.
3. Coates H, Thornton R, Langlands J, Filion P, Keil AD, Vijayasekaran S, Richmond P. 2008. The role of chronic infection in children with otitis media with effusion: evidence for intracellular persistence of bacteria. Otolaryngol. Head Neck Surg. 138:778-781.
4. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PWM, Orihuela CJ. 2010. The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog. 6:e1001044. doi:10.1371 /journal.ppat.1001044.
5. Costerton JW, Steward PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
6. Domenech M, García E, Moscoso M. 2012. Biofilm formation in Streptococcus pneumoniae. Microb. Biotechnol. 5:455-465.
7. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193.
8. Walport MJ. 2001. Complement. First of two parts. N. Engl. J. Med. 344:1058-1066.
9. Walport MJ. 2001. Complement. Second of two parts. N. Engl. J. Med. 344:1140-1144.
10. Brown JS, Hussell T, Gilliland SM, Holden DW, Paton JC, Ehrenstein MR, Walport MJ, Botto M. 2002. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. U. S. A. 99:16969-16974.
11. Yuste J, Sen A, Truedsson L, Jönsson G, Tay LS, Hyams C, Baxendale HE, Goldblatt F, Botto M, Brown JS. 2008. Impaired opsonization with C3b and phagocytosis of Streptococcus pneumoniae in sera from subjects with defects in the classical complement pathway. Infect. Immun. 76: 3761-3770.
12. Hyams C, Camberlein E, Cohen JM, Bax K, Brown JS. 2010. The Streptococcus pneumoniae capsule inhibits complement activity and neutrophil phagocytosis by multiple mechanisms. Infect. Immun. 78:704- 715.
13. Xu Y, Ma M, Ippolito GC, Schroeder HW, Jr, Carroll MC, Volanakis JE. 2001. Complement activation in factor D-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 98:14577-14582.
14. Ali YM, Lynch NJ, Haleem KS, Fujita T, Endo Y, Hansen S, Holmskov U, Takahashi K, Stahl GL, Dudler T, Girija UV, Wallis R, Kadioglu A, Stover CM, Andrew PW, Schwaeble WJ. 2012. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLoS Pathog. 8:e1002793. doi:10.1371 /journal.ppat.1002793.
15. Vuong C, Kocianova S, Voyich JM, Yao Y, Fischer ER, DeLeo FR, Otto M. 2004. A crucial role for exopolysaccharide modification in bacterial biofilm formation, immune evasion, and virulence. J. Biol. Chem. 279: 54881-54886.
16. Simmons WL, Dybvig K. 2007. Biofilms protect Mycoplasma pulmonis cells from lytic effects of complement and gramicidin. Infect. Immun. 75:3696-3699.
17. King LB, Swiatlo E, Swiatlo A, McDaniel LS. 2009. Serum resistance and biofilm formation in clinical isolates of Acinetobacter baumannii. FEMS Immunol. Med. Microbiol. 55:414-421.
18. Hoskins J, Alborn WE, Jr, Arnold J, Blaszczak LC, Burgett S, DeHoff BS, Estrem ST, Fritz L, Fu Fuller D-JW, Geringer C, Gilmour R, Glass JS, Khoje H, Kraft AR, Lagace RE, LeBlanc DJ, Lee LN, Lefkowitz EJ, Lu J, Matsushima P, McAhren SM, McHenney M, McLeaster K, Mundy CW, Nicas TI, Norris FH, O'Gara M, Peery RB, Robertson GT, Rockey P, Sun PM, Winkler ME, Yang Y, Young-Bellido M, Zhao G, Zook CA, Baltz RH, Jaskunas R, Rosteck PRJ, Skatrud PL, Glass JI. 2001. Genome of the bacterium Streptococcus pneumoniae strain R6. J. Bacteriol. 183: 5709-5717.
19. Moscoso M, García E, López R. 2006. Biofilm formation by Streptococcus pneumoniae: role of choline, extracellular DNA, and capsular polysaccharide in microbial accretion. J. Bacteriol. 188:7785-7795.
20. Lacks S, Hotchkiss RD. 1960. A study of the genetic material determining an enzyme activity in Pneumococcus. Biochim. Biophys. Acta 39:508-518.
21. Domenech M, García E, Moscoso M. 2009. Versatility of the capsular genes during biofilm formation by Streptococcus pneumoniae. Environ. Microbiol. 11:2542-2555.
22. Yuste J, Botto M, Bottoms SE, Brown JS. 2007. Serum amyloid P aids complement-mediated immunity to Streptococcus pneumoniae. PLoS Pathog. 3:e120. doi:10.1371/journal.ppat.0030120.
23. Ramos-Sevillano E, Moscoso M, García P, García E, Yuste J. 2011. Nasopharyngeal colonization and invasive disease are enhanced by the cell wall hydrolases LytB and LytC of Streptococcus pneumoniae. PLoS One 6:e23626. doi:10.1371/journal.pone.0023626.
24. Fleck RA, Romero-Steiner S, Nahm MH. 2005. Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies. Clin. Diagn. Lab. Immunol. 12:19-27.
25. Dave S, Brooks-Walter A, Pangburn MK, McDaniel LS. 2001. PspC, a pneumococcal surface protein, binds human factor H. Infect. Immun. 69:3435-3437.
26. Hammerschmidt S, Agarwal V, Kunert A, Haelbich S, Skerka C, Zipfel PF. 2007. The host immune regulator factor H interacts via two contact sites with the PspC protein of Streptococcus pneumoniae and mediates adhesion to host epithelial cells. J. Immunol. 178:5848-5858.
27. Yuste J, Khandavilli S, Ansari N, Muttardi K, Ismail L, Hyams C, Weiser J, Mitchell T, Brown JS. 2010. The effects of PspC on complement-mediated immunity to Streptococcus pneumoniae vary with strain background and capsular serotype. Infect. Immun. 78:283-292.
28. Kadioglu A, Weiser JN, Paton JC, Andrew PW. 2008. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6:288-301.
29. Moscoso M, Domenech M, García E. 2011. Vancomycin tolerance in Gram-positive cocci. Environ. Microbiol. Rep. 3:640-650.
30. Kristian SA, Birkenstock TA, Sauder U, Mack D, Götz F, Landmann R. 2008. Biofilm formation induces C3a release and protects Staphylococcus epidermidis from IgG and complement deposition and from neutrophildependent killing. J. Infect. Dis. 197:1028-1035.
31. Tong HH, Li YX, Stahl GL, Thurman JM. 2010. Enhanced susceptibility to acute pneumococcal otitis media in mice deficient in complement C1qa, factor B, and factor B/C2. Infect. Immun. 78:976-983.
32. Almirall J, Bolíbar I, Toran P, Pera G, Boquet X, Balanzó X, Sauca G. 2004. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia. Chest 125:1335-1342.
33. Klingenberg C, Aarag E, Rønnestad A, Sollid JE, Abrahamsen TG, Kjeldsen G, Flaegstad T. 2005. Coagulase-negative staphylococcal sepsis in neonates. Association between antibiotic resistance, biofilm formation and the host inflammatory response. Pediatr. Infect. Dis. J. 24:817-822.
34. Sanchez CJ, Kumar N, Lizcano A, Shivshankar P, Dunning Hotopp JC, Jorgensen JH, Tettelin H, Orihuela CJ. 2011. Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production. PLoS One 6:e28738. doi:10.1371/journal.pone .0028738.
35. Agrawal A, Shrive AK, Greenhough TJ, Volanakis JE. 2001. Topology and structure of the C1q-binding site on C-reactive protein. J. Immunol. 166:3998-4004.
36. McGrath FD, Brouwer MC, Arlaud GJ, Daha MR, Hack CE, Roos A. 2006. Evidence that complement protein C1q interacts with C-reactive protein through its globular head region. J. Immunol. 176:2950-2957.
37. Terrasse R, Tacnet-Delorme P, Moriscot C, Perard J, Schoehn G, Vernet T, Thielens NM, Di Guilmi AM, Frachet P. 2012. Human and pneumococcal cell surface glyceraldehyde-3-phosphate dehydrogenase (GAPDH) proteins are both ligands of human C1q protein. J. Biol. Chem. 287:42620-42633.
38. Lambris JD, Ricklin D, Geisbrecht BV. 2008. Complement evasion by human pathogens. Nat. Rev. Microbiol. 6:132-142.
39. Agarwal V, Hammerschmidt S, Malm S, Bergmann S, Riesbeck K, Blom AM. 2012. Enolase of Streptococcus pneumoniae binds human complement inhibitor C4b-binding protein and contributes to complement evasion. J. Immunol. 189:3575-3584.
40. Dieudonné-Vatran A, Krentz S, Blom AM, Meri S, Henriques-Normark B, Riesbeck K, Albiger B. 2009. Clinical isolates of Streptococcus pneumoniae bind the complement inhibitor C4b-binding protein in a PspC allele-dependent fashion. J. Immunol. 182:7865-7877.
41. Henderson B, Martin A. 2011. Bacterial virulence in the moonlight: multitasking bacterial moonlighting proteins are virulence determinants in infectious disease. Infect. Immun. 79:3476-3491.
42. Allegrucci M, Hu FZ, Shen K, Hayes J, Ehrlich GD, Post JC, Sauer K. 2006. Phenotypic characterization of Streptococcus pneumoniae biofilm development. J. Bacteriol. 188:2325-2335.
43. Sanchez CJ, Hurtgen BJ, Lizcano A, Shivshankar P, Cole GT, Orihuela CJ. 2011. Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera. BMC Microbiol. 11:245.
44. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. 2006. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect. Immun. 74:4849- 4855.
45. Thurlow LR, Hanke ML, Fritz T, Angle A, Aldrich A, Williams SH, Engebretsen IL, Bayles KW, Horswill AR, Kielian T. 2011. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186:6586-6596.
46. Domenech M, Garcia E, Prieto A, Moscoso M. 2013. Insight into the composition of the intercellular matrix of Streptococcus pneumoniae biofilms. Environ. Microbiol. 15:502-516.
47. Trappetti C, Ogunniyi AD, Oggioni MR, Paton JC. 2011. Extracellular matrix formation enhances the ability of Streptococcus pneumoniae to cause invasive disease. PLoS One 6:e19844. doi:10.1371/journal.pone .0019844.